Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
02:05pm, Friday, 14'th Jun 2024
Novavax's updated JN.1 COVID-19 vaccine is active against current circulating strains, including KP.2 and KP.3 Novavax's JN.1 COVID-19 vaccine would be the only protein-based option available in the U
Is It Too Late to Buy Novavax Stock?
04:55am, Friday, 14'th Jun 2024
Novavax's stock is highly volatile due to the company's instability and inconsistent financial results. Sanofi has partnered with the company, and that has sparked a wave of excitement in Novavax's st
3 Penny Stocks Set to Surge 500% by 2026: June Edition
11:02am, Thursday, 13'th Jun 2024
Penny stocks have the tendency to surprise when it comes to delivering stellar returns at the blink of an eye. A good example is Novavax (NASDAQ: NVAX ) that has delivered 203% returns for year-to-dat
Top 4 Large-Cap Stocks With Major Short Interest
07:36am, Thursday, 13'th Jun 2024
With the ongoing GameStop saga reigniting interest in meme stocks, investors, or more likely traders and speculators, are once again seeking out stocks with high short interest. As the overall market,
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
06:00am, Tuesday, 11'th Jun 2024
On Friday, the U.S. Federal Drug Administration (FDA) okayed the launch of updated vaccines as part of the 2024-2025 campaign against new Covid strains. Drug manufacturers have been waiting on appro
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
05:10am, Tuesday, 11'th Jun 2024
The S&P 500 has hit more than one record high this year, and technology stocks have led the gains. It's a great idea to get in on stocks that have remained in the doldrums but could have a bright futu
3 Biotech Stocks to Monitor Right Now
03:33pm, Monday, 10'th Jun 2024
Last week, we profiled biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) amid a historically bullish month.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
10:05am, Monday, 10'th Jun 2024
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Novavax, Inc. (NVAX) Jefferies 2024 Global Healthcare Conference (Transcript)
02:33am, Sunday, 09'th Jun 2024
Novavax, Inc. (NASDAQ:NVAX ) Jefferies 2024 Global Healthcare Conference June 6, 2024 12:30 PM ET Company Participants John Jacobs - President and CEO Filip Dubovsky - Chief Development Officer Jim Ke
Novavax Stock's Recent Surge and Future Potential
12:33pm, Thursday, 06'th Jun 2024
Novavax NASDAQ: NVAX is a drug and vaccine manufacturer in the healthcare sector known for its efforts in the COVID-19 vaccine market. Novavax's stock price has experienced a remarkable surge recently
Novavax stock rises on COVID vaccine delivery projections
11:51am, Thursday, 06'th Jun 2024
Shares of Novavax (NVAX) are surging after the company announced it will meet delivery expectations for the fall COVID vaccine push. All COVID vaccines will use the JN.1 strain, part of the Omicron su
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
09:28am, Thursday, 06'th Jun 2024
Vaccine maker Novavax (NASDAQ: NVAX ) saw its shares jump 18% on June 5 and another 20% in pre-market trade this morning. NVAX stock is up over 300% year-to-date.
Novavax, With A 369% Gain, Tears Ahead Again On Key FDA Move
09:14am, Thursday, 06'th Jun 2024
Novavax stock zipped to a nearly two-year high Thursday after the FDA set a potential approval date for its Covid vaccine in April.
My Novavax stock price forecast was correct: what next now?
12:05am, Thursday, 06'th Jun 2024
Novavax (NASDAQ: NVAX) stock price has gone parabolic this year, making it one of the best-performing companies in New York. It has soared by over 335% in 2024 and by almost 500% from its lowest level
FDA advisers urge targeting JN.1 strain in fall's COVID vaccines
07:46pm, Wednesday, 05'th Jun 2024
WASHINGTON — Government advisers Wednesday said it's time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of the ever-evolving coronavirus c
